Syneron Medical launches its elōs Plus next-generation multi-platform aesthetic treatment system in Canada, following the company's recent commercial distribution in U.S., Europe and Asia.
Israeli aesthetic device company Syneron Medical (NSDQ:elōs) received Health Canada clearance and launched its elōs Plus next-generation multi-platform system in Canada. The updated systems combines light modality with radiofrequency to allow doctors to treat patients of all skin types, the company said.
"The new elōs Plus was designed with this dynamic in mind – it is built to out-deliver the competition in performance, versatility, reliability and scalability to meet the needs of today's aesthetic practitioners," CEO Louis Scafuri said in prepared remarks. "Our customers in the U.S., Europe and Asia have been very pleased with all the features we were able to put inside the elōs Plus and we are excited to now offer the system to our physician partners in Canada."